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INTRODUCTION 
Acute pancreatitis is a common, sometimes life
threatening disorder in companion animals. Clinical
signs and laboratory abnormalities of patients with
acute pancreatitis can resemble other diseases. There-
fore, the diagnosis can be challenging for the practi -
tioner. However, a rapid and correct diagnosis
facilitates early therapy, which improves the chances
of survival. This report is the first in a series of three
that will present a review of acute pancreatitis in dogs
and cats. Pathogenesis and underlying factors are des-
cribed, followed by an overview of the most common
clinical signs. Finally, the advantages and disadvanta-
ges of some possible diagnostic laboratory methods
are summarized. The second article will discuss the
medical imaging, treatment and prognosis of acute
pancreatitis in small animals. Two clinical cases will
be discussed in the final report.   
FUNCTION OF THE NORMAL PANCREAS
The pancreas consists mainly of exocrine tissue
(98%), with the endocrine islets of Langerhans com-
posing the remaining 2% (Watson, 2004). The major
function of the exocrine acinar cells is to produce,
store and secrete a fluid rich in enzymes that helps in
the initial digestion of proteins, lipids and polysaccha-
rides (Williams, 2000). The pancreas produces lipase,
α-amylase, phospholipase A2, elastases, carboxypep-
tidases, trypsin and chymotrypsin (Bunch, 2003; Wat-
son, 2004; Mix and Jones, 2006). 
PREVALENCE AND PATHOGENESIS OF ACUTE
PANCREATITIS 
Acute pancreatitis is defined as pancreatic necro-
sis, often with a neutrophilic infiltrate. Because there
is no fibrosis or chronic inflammation that disrupts the
normal architecture of the pancreas, as in the case of
chronic pancreatitis, acute pancreatitis is a completely
reversible process (Watson et al., 2007). It represents
a spectrum of disease, ranging from mild to severe and
from a single episode to recurrent episodes (Watson,
2004; Watson, 2007). The true prevalence of pancrea-
titis is probably underestimated because of the diffi-
cult ante-mortem diagnosis (Mix and Jones, 2006;
Watson, 2007). In a post-mortem examination of 200
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ABSTRACT
Acute pancreatitis is a (usually sterile) inflammation with acute onset and characterized by necrosis and
edema; it does not permanently disrupt the pancreatic architecture and is completely reversible. It is thought
that, despite the pancreatic defense mechanisms, premature activation of trypsin in the acinar cells starts a
cascade of reactions that result in autodigestion. Most cases are idiopathic. Dogs are often presented with
gastrointestinal signs, whereas lethargy and anorexia are the most commonly observed symptoms in cats.
Diagnosing pancreatitis remains a challenge, but the recent development of the pancreatic lipase
immunoreactivity test is promising. 
SAMENVATTING
Acute pancreatitis is een plotse (meestal steriele) ontsteking die de structuur van de pancreas niet definitief
aantast en die compleet reversibel is. Deze ontsteking wordt gekarakteriseerd door necrose en oedeem. Er wordt
verondersteld dat, ondanks verdedigingsmechanismen, een vroegtijdige activering van trypsin in de acinaire cellen
een cascade van reacties veroorzaakt met autodigestie tot gevolg. De meeste gevallen zijn idiopathisch. Honden
worden vaak aangeboden met gastro-intestinale klachten, terwijl lethargie en anorexie de meest voorkomende
symptomen zijn bij katten. Het diagnosticeren van pancreatitis blijft een uitdaging maar de recente ontwikkeling
van de “pancreatic lipase immunoreactivity” test is veelbelovend. 
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dogs (whose history and complaints were often not
known) (Watson et al., 2007), 34% showed lesions
compatible with chronic pancreatitis, and only 2.6%
showed lesions of the acute form. This difference in
prevalence can partially be explained by the fact that
dogs who recover from acute pancreatitis might not
show any histological evidence. De Cock et al. (2007)
found a 15.7% prevalence of acute pancreatitis in cats,
which is higher than in dogs, but still less common
than the chronic form (prevalence of 60%). Of the cats
with acute pancreatitis, only 9.6% also suffered from
chronic pancreatitis, which is in contrast to the con-
clusion of Forman et al. (2004), who found this com-
bination of lesions in 44% of their patients.
The exact mechanism by which acute pancreatitis
develops is still incompletely understood. In normal
conditions, a number of pancreatic defense mecha-
nisms are available to prevent autodigestion. Proteo-
lytic enzymes are synthesized and secreted in the form
of catalytically inactive precursors called zymogens
(for example trypsinogen) (Steiner, 2003a; Watson,
2004; Mix and Jones, 2006). In the acinar cell, damage
by lysosomal proteases is prevented by the storage of
zymogens in granules (Watson, 2004; Mix and Jones,
2006). The activation of zymogens occurs by cleavage
of an activation peptide of the polypeptide chain, but
this normally does not occur until they are secreted
into the small intestine. The first zymogen activated is
trypsinogen, which is cleaved by enteropeptidase syn-
thesized by the enterocytes of the duodenal mucosa to
form trypsin. Trypsin plays a central role in the acti-
vation cascade by cleaving the activation peptides
from the other zymogens and itself (Watson, 2004;
Mix and Jones, 2006). At least two mechanisms are
available to prevent further damage in the event of
inappropriate early intra-pancreatic activation of pro-
teases. The first mechanism involves small amounts of
trypsin that can hydrolyze itself (Watson, 2004). The
other possibility is the temporary binding of trypsin to
pancreatic secretory trypsin inhibitor (PSTI). This is a
low-molecular-weight molecule that is present in the
zymogens and that can inactivate approximately 10
percent of the total amount of trypsin (Watson, 2004;
Mix and Jones, 2006). Plasma protease inhibitors play
an important role as protection mechanisms against the
possible fatal effects of protease release in the vascu-
lar space. Alpha-macroglobulins (α-M1 and α-M2)
and α1-proteinase inhibitors (α-1-antitrypsin) inhibit
neutrophil elastase and form complexes with protea-
ses, which are then removed from the plasma by the re-
ticulo-endothelial system. This removal is crucial,
because the bound proteases retain their proteolytic ac-
tivity (Steiner, 2003a). 
It is thought that inappropriate premature activa-
tion of trypsin in the acinar cells initiates a cascade of
early activation of zymogens, especially proelastase
and prophospholipase, with autodigestion of the pan-
creas as a result (Bunch, 2003; Watson, 2004). Acti-
vation of intracellular enzymes results in cellular
necrosis and subsequent sterile inflammation, which
leads to peri-pancreatic fat necrosis. Activated enzy-
mes can cause vascular injury and activation of coa-
gulation and vasoactive amine, fibrinolytic and com -
plement cascades. Enzyme release in the abdomen can
result in local or generalized peritonitis (Bunch, 2003;
Steiner, 2003a; Watson, 2004; Mix and Jones, 2006).
The release of proteases in the systemic circulation can
overwhelm the protection mechanism and result in
systemic inflammatory response syndrome and multi-
organ failure. The production of potent proteolytic en-
zymes, oxidative substances such as H2O2, and
pro-inflammatory cytokines plays an important role in
the progression of pancreatitis and in the development
of multiple organ failure (Ruaux, 2000; Brady and
Otto, 2001). 
PREDISPOSING FACTORS OF ACUTE PAN-
CREATITIS
The triggering factors of acute pancreatitis in dogs
and cats are usually unknown and most cases are con-
sidered idiopathic, although the practitioner should
certainly be on the lookout for possible underlying fac-
tors (Simpson, 2001a; Washabau, 2001; Watson, 2004;
Zoran, 2006; Watson, 2007). Possible risk factors are
shown in Table 1. Cholangiohepatitis and inflamma-
tory bowel disease (IBD) are often coexisting disor-
ders in cats suffering from acute pancreatitis (also
called the triade disease or triaditis) (Weiss et al.,
1996). In cats with cholangiohepatitis, the concurrent
pancreatic lesions are usually mild, while the IBD
tends to be severe (Weiss et al., 1996). The reason why
cholangiohepatitis is often a concurrent disease in cats
with pancreatitis, and not in dogs, can be explained by
the different anatomic construction of the pancreatic
and bile ducts in these two species. Hepatic lipidosis is
another disease often diagnosed in cats with acute pan-
creatitis (Akol et al., 1993). 
CLINICAL SIGNS OF ACUTE PANCREATITIS
The clinical signs of acute pancreatitis in dogs and
cats are nonspecific and similar to those of numerous
other gastrointestinal pathologies and metabolic dis -
orders. Furthermore, they vary with the severity of the
disease. Most typically, dogs present with anorexia
(91%), acute vomiting (90% of which 10% hemate-
mesis) and weakness (79%) (Hess et al., 1998). Small
or large bowel diarrhea is described in 33% of the
cases (Hess et al., 1998). The majority of cats are re-
ferred to a veterinarian because of lethargy (50%-
100%), anorexia (63%-100%), dehydration (33%-
92%) or tachypnoea (74%) (Hill and Van Winkle,
1993; Gerhardt et al., 2001; Ferreri et al., 2003). In
contrast to dogs, gastrointestinal signs are rather sparse
in cats (Hill and Van Winkle, 1993; Gerhardt et al.,
2001; Ferreri et al., 2003). Possible clinical signs and
physical examination findings are reported in Table 2.
In more severely affected dogs, collapse and shock
can occur (Simpson and Lamb, 1995; Bunch, 2003;
Vlaams Diergeneeskundig Tijdschrift, 2010, 79 15
Watson, 2004; Mix and Jones, 2006; Watson, 2007).
Possible complications due to systemic inflammatory
response syndrome in these patients include hypoten-
sion, cardiac arrhythmias (usually ventricular), pan-
creatic abscesses or cysts, diabetes/diabetes keto-
acidosis, intestinal obstruction and acute renal failure
(Bunch, 2003; Mansfield et al., 2003; Watson, 2004;
Mix and Jones, 2006). Damage to endothelial cells,
mediated by proteolytic enzymes and oxidants, can
lead to activation of the extrinsic coagulation pathway,
resulting in disseminated intravascular coagulation
(DIC) and thromboembolism (Ruaux, 2000). Intersti-
tial edema can result from increased vascular permea-
bility of the pulmonary vessels. This condition can
cause ventilation-perfusion mismatches and, in the
end, acute respiratory distress syndrome (ARDS) and
organ hypoxia. Another factor that can contribute to
ARDS is the activation of phospholipase A2 and elas-
tase, which results in pulmonary surfactant degrada-
tion. Pleural effusion and pulmonary thromboem -
bolism can also deteriorate the respiratory function
(López et al., 1995; Ruaux, 2000; Mansfield et al.,
2003). Absorption of endotoxin from the compromised
adjacent areas of gut can contribute to sepsis and
Table 1. Risk factors for the development of acute pancreatitis in dogs and cats. 
Risk factor Dog Cat
Breed Terrier or non-sporting breed1,2,3,4 Domestic shorthair breeds and Siamese5,6,7
Gender Controversial (no gender predilection, Controversial (no gender predisposition, 
intact males, neutered dogs)1,2,3,4 neutered males)5,6,7
Age Middle-aged to older1,2,8 No age predisposition, in most cases cats older
than 7 years, suppurative form more in younger
animals (mean age 3.5 years)5,7
Ischemia Hypovolemia, shock, hypotension, Decreased blood flow and alterations 
severe anemia, infarct, vasoactive amine- in microvascular permeability9,10
induced vasoconstriction, disseminated intra-
vascular coagulation, temporary venous
occlusion during surgery in the cranial 
abdomen1,3,4
Diet High-fat diet, obesity, malnutrition1,2,4,8,11,12 Not reported
Hyperlipidemia Inherent abnormal lipid metabolism Not reported
(Miniature schnauzers)4,9,11, accumulation of
toxic fatty acids in the pancreas1, ingestion of
a large fatty meal3, concurrent disease2,4,13
Concurrent disease Diabetes mellitus13, hypercortisolism13, Cholangiohepatitis, inflammatory bowel disease, 
hypothyroidism2,4 hepatic lipidosis14,15
Pancreatic duct Biliary calculi (uncommon in dogs), sphincter Biliary duct obstruction9,10 due to cholelithiasis, 
obstruction spasm, tumor, trauma, surgical intervention, inspissated bile, trauma, neoplasia or stricture
parasites, cholangitis, edema of the duct
through the duodenal wall and maybe
congenital anomalies4
Reflux of duodenal Abnormally high intraluminal pressure Not reported
fluid (vomiting, trauma of the duodenum)3
Drugs Thiazide diuretics, furosemide, azathioprine, Organophosphates, steroids?9
L-asparaginase, sulfonamides, tetracyclines,
procainamide, organophosphates, cholinergic
agonists, oestrogens4, potassiumbromide in
combination with phenobarbital16, steroids
(only in association with intervertebral disc
disease and surgery), propofol?4
Infection Viral, parasitic, mycoplasmal, bacterial?3 Feline infectious peritonitis, Toxoplasma gondii,
Herpesvirus, Amphimerus pseudofelineus10
Trauma Surgical manipulation, pancreatic biopsy and Surgical manipulation, high rise syndrome9,10
car accidents (abdominal trauma)4,8,11,13
Other causes Uremic pancreatitis1, prior gastrointestinal disease2, Uremia, hypercalcemia, lipodystrophia9,10
hypercalcemia4,11 and thrombus formation2
Adapted from: 1Cook et al., 1993; 2Hess et al., 1999; 3Bunch, 2003; 4Watson, 2004; 5Hill and Van Winkle, 1993; 6Kimmel et al., 2001; 7Ferreri et al., 2003;
8Mix and Jones, 2006; 9Simpson, 2001b; 10Washabau, 2001; 11Simpson and Lamb, 1995; 12Hess et al., 1998; 13Watson, 2007;  14Weiss et al., 1996; 15Akol et
al., 1993; 16Gaskill and Gribb, 2000.
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multi-organ failure (Watson, 2004). Extrahepatic
biliary obstruction (EHBO) can develop secondary to
peri-pancreatic inflammation and edema, because one
of the pancreatic ducts ends next to the bile duct in the
major duodenal papilla. Acute pancreatitis seems to be
one of the most common causes of EHBO in dogs
(Herman et al., 2005; Mayhew et al., 2006).
Thirty-eight percent of cats have acute cardiovas-
cular shock at presentation (Hill and Van Winkle,
1993). Complications are largely the same as those in
dogs (Washabau, 2001). However, in contrast to dogs,
acute pancreatitis was not found to be a risk factor in
two studies on cats with EHBO (Bacon and White,
2003; Buote et al., 2006). In a retrospective study, ne-
cropsy was performed on 40 cats with acute pancrea-
titis: 20% of them had thrombosis, although it was not
specified whether this was venous or arterial, and the
localization of the thrombosis was not mentioned.
Lung lesions were present in 30% of the cats: pulmo-
nary edema, a sign of ARDS, was the most common
pathology, although it could have developed secondary
to fluid administration. Other complications included
pleural effusion (12%), abdominal effusion (7.4%), a
combination of pleural and abdominal effusion (22%),
and pericardial effusion (5%) (Hill and Van Winkle,
1993).
CLINICOPATHOLOGIC FINDINGS
Because acute pancreatitis can be a severe and po-
tentially life threatening disease, an accurate and ti-
mely diagnosis is essential. An ideal diagnostic marker
should be inexpensive, easily available and non-inva-
sive. Other essential characteristics are that the mar-
ker should have a high specificity (low number of false
positive results) in combination with a high sensitivity
(low number of false negative results). Because an
ideal test does not yet exist, diagnosing acute pan-
creatitis remains a challenge. Biopsy and histological
examination of pancreatic tissue remains the gold stan-
dard, and in absence of this test the diagnosis can only
be tentative. Nevertheless, careful evaluation of the en-
tire clinical picture can help in confirming the suspi-
cion and excluding other differential diagnoses such
as intestinal foreign bodies, gastroenteritis, peritonitis
and pyometra, all of which can cause an acute abdo-
men. A comparison of different diagnostic tests can be
found in Table 3. 
Complete blood count 
Hematologic findings are nonspecific in dogs and
cats with acute pancreatitis. Leucocytosis is a more
common finding in dogs (62%) than in cats (30%),
while leucopenia is more typically found in cats (15%
versus 3.3%) (Hill and Van Winkle, 1993; Hess et al.,
1998; Watson, 2004). However, according to Gerhardt
et al. (2001), leucocytosis is present in 62% of cats
with acute pancreatitis. In more severe cases of acute
pancreatitis in dogs and cats, a degenerative left shift
or toxic white blood cells can be present (Hill and Van
Winkle, 1993; Simpson and Lamb, 1995; Hess et al.,
1998). Fifty-five percent of cats show normochromic,
normocytic regenerative anemia (Hill and Van Winkle,
1993), while only 28.6% of affected dogs have
decreased red blood cell concentrations (Hess et al.,
1998). Hemoconcentration resulting from dehydration
(Mansfield and Jones, 2001; Bunch, 2003; Watson,
2004) is also possible. Thrombocytopenia can follow
the development of DIC (Hess et al., 1998; Simpson
and Lamb, 1995; Bunch, 2003; Watson, 2004). It is
recommended to test coagulation profiles in all dogs
Table 2. Prevalence of clinical signs and physical examination findings in dogs and cats with acute pancreatitis in
percentages (%).
Clinical signs Dogs1 Cats2,3,4,5
Anorexia 91 63 - 100
Acute vomiting 90 (with 10% hematemesis) 35 - 52
Weakness / Lethargia 79 50 - 100
Polyuria/polydipsia 50 20
Diarrhea 33 (with 16% melena and 4% hematoschezie) 11 - 15
Neurological symptoms 20 15
Weight loss 11 33
Tachypnoea No prevalence reported 74
Dyspnoea No prevalence reported 20
Physical examination findings
Dehydration 97 33 - 92
Painful abdominal palpation 58 9 - 25
Fever 32 7
Icterus 26 16 - 64
Cardiac murmur 20 No prevalence reported
Blood coagulation abnormalities 11 No prevalence reported
Hypothermia 7 68
Adapted from: 1Hess et al., 1998; 2Hill and Van Winkle, 1993; 3Gerhardt et al., 2001; 4Kimmel et al., 2001; 5Ferreri et al., 2003.
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and cats suspected of acute pancreatitis, and obligatory
if they have thrombocytopenia (Hill and Van Winkle,
1993; Hess et al., 1998).
Serum biochemistry
Azotemia is often present in dogs (59%) and cats
(33%) with acute pancreatitis, and is usually pre-renal
in origin (Hill and Van Winkle, 1993; Hess et al., 1998;
Gerhardt et al., 2001; Bunch, 2003). Several factors
can play a role: volume contraction from vomiting,
lack of fluid intake and extravasation of fluid into a
third space from vascular injury (Bunch, 2003). 
Hepatic ischemia, local inflammatory mediators
and toxic pancreatic mediators in the portal circulation
lead to hepatocellular injury with increased liver en-
zymes in both dogs and cats (alanine ALT and aspar-
tate AST aminotransferase) (Hill and Van Winkle,
1993; Hess et al., 1998). Hyperbilirubinemia (twofold
to fivefold increase), present in 30 - 53% of dogs and
38 - 64% of cats, can be noticed in cases of cholesta-
sis (Hill and Van Winkle, 1993; Hess et al., 1998; Ger-
hardt et al., 2001; Washabau, 2001). This cholestasis
develops secondary either to pancreatic inflammation
or to fibrosis, which obstructs (partially or completely)
the common bile duct (Bunch, 2003; Watson, 2004;
Mix and Jones, 2006). Cholestasis can also result in
increased AST, ALT and alkaline phosphatise (AP)
(Watson, 2004). 
Sixty-five percent of dogs and cats with acute pan-
creatitis have hyperglycemia, which can develop due
to glucagon release in excess of insulin from an in fla-
med pancreas, in combination with stress-related
in creases of cortisol and catecholamines (Hill and Van
Winkle, 1993; Bunch, 2003; Watson, 2004). Concur-
rent diabetes mellitus or keto-acidosis or the develop-
ment of diabetes after acute episodes of pancreatitis is
another possible explanation for the detected hyper-
glycemia (Watson, 2004). Diabetes mellitus is more
common in dogs with pancreatitis (13.9%) than in cats
with pancreatitis (1%) (Cook et al., 1993; Ferreri et al.,
2003). Pancreatitis is the most common concurrent
dis order in dogs with diabetes keto-acidosis (41%)
(Hume et al., 2006; De Causmacker et al., 2009). More
severe cases of acute pancreatitis are usually charac-
terized by hypoglycemia (39%) (Hess et al., 1998).
This latter abnormality can occur secondary to reduced
calorie intake, severe sepsis and concurrent liver di-
sease (Watson, 2004). 
Almost half of dogs and two-thirds of cats have
high serum hypercholesterolemia (Hill and Van Win-
kle, 1993; Hess et al., 1998). Hypertriglyceridemia is
another common but nonspecific finding (Bunch,
2003). Hyperlipemia can be either a cause or, more li-
kely, a result of the disease (Watson, 2004). In addi-
tion, hyperlipemia can be associated with other
diseases, such as endocrinopathies and hepatic lipido-
sis, that can concurrently affect both dogs and cats
with pancreatitis (Hill and Van Winkle, 1993; Mans-
field and Jones, 2001).
Mild to moderate hypocalcemia is rare in dogs with
pancreatitis (3-5%) (Simpson and Lamb, 1995; Hess et
al., 1998; Hess et al., 1999), but a frequent finding in
cats (45 - 61%), although in only 9% of cats is calcium
markedly depressed (Ca < 1.75 mmol/l; reference 2-
2.75 mmol/l) (Hill and Van Winkle, 1993; Kimmel et
al., 2001). Although hypocalcemia rarely causes clini-
cal signs such as neurologic or cardiac abnormalities,
it is associated with a worse clinical outcome. Fifty-
three percent of cats that did not survive in the study of
Kimmel et al. (2001) had a plasma ionized calcium
concentration below or equal to 1 mmol/l (reference
1.10-1.28 mmol/l). The mechanism of hypocalcemia
is not yet known, though it is assumed that depositions
of calcium (such as soaps in peri-pancreatic fat), an
acute shift of calcium into soft tissues, and hormonal
imbalances (e.g. thyrocalcitonine and abnormal para -
thyroid responsiveness) are possible factors (Bunch,
2003; Watson, 2004; Mix and Jones, 2006).   
Vomiting and reduced food intake can lead to hypo-
Table 3. Specificity and sensitivity of different tests for diagnosing acute pancreatitis.
Diagnostic test Dog Cat
Specificity (%) Sensitivity (%) Specificity (%) Sensitivity (%)
Serum amylase 572 62 - 691,2 No diagnostic value
Serum lipase 552 39 - 731,2 No diagnostic value
cTLI 652 33 - 363,6
fTLI 825 28 - 33 (if upper ref fTLI > 100 µg/l) 4,5
48 (if upper ref fTLI > 88 µg/l)5
62 (if upper ref fTLI > 82 µg/l)5
86 (if upper ref fTLI > 49 µg/l)5
cPLI 803 61 - 803,6
fPLI 914 674
Serum TAP 76 - 902,7 53 - 542 Not determined
UTCR Not determined 262 No diagnostic value
cTLI = canine trypsin like immunoreactivity; fTLI = feline trypsin like immunoreactivity; cPLI = canine pancreatic lipase immunoreactivity; fPLI = feline pancreatic lipase
immunoreactivity; TAP = trypsinogen activation peptide; UTCR = urinary TAP-to- creatinine ratio 
Adapted from: 1Hess et al., 1998; 2Mansfield and Jones, 2000b; 3Steiner et al., 2001a; 4Forman et al., 2004; 5Gerhardt et al., 2001; 6Steiner et al., 2007; 7Mansfield et al.,
2003
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natremia, hypochloremia and hypokalemia (Watson,
2004). In dogs, hypochloremia is the most frequent
electrolyte abnormality (81.3%), while hypokalemia
is more common in cats (56%) (Hill and Van Winkle,
1993; Hess et al., 1998). Hypophosphatemia is an in-
frequent finding in cats (14%), but can be important
to monitor, because uncorrected hypophosphatemia
can result in hemolytic anemia, neuromuscular disor-
ders and intestinal ileus (Hill and Van Winkle, 1993;
Nelson, 2003).
Hyperproteinemia can be observed with dehydra-
tion (Bunch, 2003; Mix and Jones, 2006), while albu-
min can be low because of leakage due to vascular
damage (Bunch, 2003).
Metabolic acidosis is also a possible finding in both
dogs and cats (Hill and Van Winkle, 1993; Simpson
and Lamb, 1995; Hess et al., 1998).
Although blood work alone is insufficient for diag -
nosing acute pancreatitis, it might be an important step
in differentiating other diseases, in assessing the ge-
neral condition of the patient and in defining the con-
sequences and complications of pancreatitis.
More specific blood tests
Because of the shortcomings of the complete blood
work, more specific laboratory tests were developed.
Two types can be distinguished: enzymatic and im-
munoassays. Detection of released enzymes in blood
can be performed by measuring a color or density
change when the enzyme catalyzes a reaction in vitro.
Therefore enzymatic assays only measure active en-
zymes, and not inactive precursors (zymogens in the
case of pancreatitis). Furthermore, they are not species
(or organ) specific, which is another disadvantage
(Watson, 2004). The main reason that they were the
preferred test in practice for a long time is their inex-
pensiveness and availability in comparison to immu-
noassays. These latter tests detect antigens on the
surface of the molecule and therefore are independent
of the active site. They are species and organ specific
and can detect inactive precursors (Watson, 2004).
Unfortunately, they are technically demanding, and
therefore expensive and usually only available in a few
laboratories (Ruaux, 2003). For this reason, they are
not yet used in routine diagnostics. The specificities
and sensitivities of different tests are described in
Table 3.
Serum amylase and lipase are digestive enzymes
that were ‘traditionally’ used for diagnosing acute pan-
creatitis in companion animals. They originate both
from pancreatic and extra-pancreatic sources and the-
refore they are not pancreas specific. Several factors
contribute to the rather low specificity of serum amy-
lase and lipase activity in dogs. Decreased renal func-
tion, use of dexamethasone and prednisone, and
hepatobiliary and gastrointestinal diseases like lym-
phoma can all lead to elevated enzyme concentrations
in the absence of pancreatic disease (Simpson and
Lamb, 1995; Bunch, 2003; Ruaux, 2003; Steiner,
2003a; Watson, 2004). The sensitivity of lipase is hig-
her than that of amylase (Mansfield and Jones, 2000b),
although in a study of 70 fatal cases, amylase was
found to have a thirty percent higher sensitivity (Hess
et al., 1998). The reason for this was not clear.
Inflammation of the pancreas can lead to a dramatic
change in the production of proteins (especially
proteases), but this synthesis can be rapidly decreased
within hours. Also, in severe cases of pancreatitis,
normal levels can be the result of enzyme depletion or
loss of tissue (Watson, 2004). It is for this reason that
low or normal serum amylase and lipase concen -
trations may decrease, but this decrease does not
exclude the likelihood of acute pancreatitis. Mansfield
et al. (2003) believe that strongly elevated lipase
concentrations indicate more severe cases of pan -
creatitis, although Ruaux (2003) disagrees with this
finding.
In cats with acute pancreatitis, measurement of
serum lipase and amylase activities has no diagnostic
value, because the levels of both enzymes are often
within normal limits or even below baseline values
(Kitchell et al., 1986; Parent et al., 1995; Simpson,
2001a; Simpson, 2001b; Washabau, 2001). Especially
amylase is of no use because cats only produce small
amounts of amylase in comparison to dogs (Kitchell
et al., 1986). As in dogs, kidney dysfunction and extra-
pancreatic sources (e.g. inflammatory bowel disease)
can lead to increased amylase and/or lipase concen-
trations (Mansfield and Jones, 2001). 
Because of the limitations described above, neither
amylase nor lipase can be recommended as a diagnos-
tic test for pancreatitis in dogs or cats (Parent et al.,
1995). To improve the diagnostic accuracy, a pancreas
specific isoenzyme of canine amylase has been deve-
loped, but this isoenzyme is not yet commercially avai-
lable (Bunch, 2003).
Serum canine trypsin-like immunoreactivity (cTLI)
is a well known test for diagnosing exocrine pancrea-
tic insufficiency in dogs, but it can also be used for
acute pancreatitis. Early in the disease, a rapid increase
in cTLI can be detected (Bunch, 2003; Ruaux, 2003).
Elevations have a high level of specificity, although
decreased renal function can influence this result
(Simpson and Lamb, 1995; Ruaux, 2003; Watson,
2004). The sensitivity is rather low, because the period
during which cTLI is increased can be short due either
to a rapid down regulation of trypsinogen synthesis
(especially in severe cases, such as hemorrhagic ne-
crosis of pancreatic tissue) or to cleavage by endopep-
tidases (Ruaux, 2003). cTLI is a poor predictor of
outcome for acute pancreatitis (Mansfield et al., 2003).
Another limitation is that it does take several days to
run this test (Simpson and Lamb, 1995; Mix and Jones,
2006).  
Feline trypsin-like immunoreactivity (fTLI) is
considered a better marker than amylase and lipase for
feline acute pancreatitis. Indeed, Parent et al. (1995)
concluded that fTLI was significantly increased in all
12 cats with acute pancreatitis, but not in sick or
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healthy control cats, while no difference was noted in
the concentration of amylase or lipase between these
three groups of cats. However, these conclusions were
challenged by two studies that showed lower sen -
sitivities based on different upper reference values
used (Table 3) (Gerhardt et al., 2001; Forman et al.,
2004). According to Swift et al. (2000), fTLI was
poorly correlated with the histological diagnosis: only
one out of five cats with histological evidence of acute
pancreatitis had a fTLI value above the reference
range. 
The development of an enzyme-linked immuno-
sorbant assay and a radioimmunoassay for measuring
serum canine pancreatic lipase immunoreactivity
(cPLI) is an important step in diagnosing acute pan-
creatitis in dogs (Steiner and Williams, 2000; Steiner
et al., 2001c). It can be considered the single best
blood test because of its high specificity and sensiti-
vity (Steiner et al., 2001a). The high specificity results
from the fact that canine pancreatic lipase is only ex-
pressed by pancreatic acinar cells, without cross-im-
munoreactivity with other lipases or related proteins
expressed by other tissues (Steiner et al., 2000). Fur-
thermore, renal failure and administration of steroids
do not seem to contribute to elevated levels of cPLI
(Steiner et al., 2001b; Watson, 2004). In a compara-
tive study on 23 dogs with macroscopic evidence of
pancreatitis, cPLI had the highest sensitivity (60.9%),
followed by cTLI, trypsin/α1-proteinase inhibitor,
serum amylase activity and serum lipase activity (Stei-
ner et al., 2007). 
Following the development of cPLI, a variant for
the cat became available in 2002 (Wilson et al., 2002).
Feline pancreatic lipase immunoreactivity (fPLI) has a
high specificity, in combination with a high sensitivity
in more severe cases of pancreatitis (Forman et al.,
2004). Compared to fTLI, fPLI is more sensitive in
diagnosing acute pancreatitis, because the duration and
magnitude of increase of fPLI was greater in cats with
experimental pancreatitis (10 days compared to 3 days,
and 50x compared to 25x baseline value) (Williams et
al., 2003).
The principle limitation of both cPLI and fPLI is
the fact that waiting several days for results in criti-
cally ill patients is not always an option (Ruaux, 2003;
Steiner, 2003a; Steiner, 2003b; Watson, 2004; Mix and
Jones, 2006).
Because acute pancreatitis is an inflammatory pro -
cess, acute-phase response proteins such as C-reactive
protein (CRP) are released by the liver (Ruaux, 2003;
Nakamura et al., 2008). In human medicine, the
measurement of this protein constitutes an effective
tool for assessing the severity of the disease, with more
severe cases showing higher levels of CRP (Mix and
Jones, 2006). Nakamura et al. (2008) investigated CRP
levels in various diseases in 928 dogs. Acute
pancreatitis is one of the diseases with the highest CRP
levels. However, because CRP can be released
secondary to any type of inflammation, infection,
tissue damage or trauma, the specificity is too low to
play a role in diagnosing acute pancreatitis (Spillman
et al., 2002; Mix and Jones, 2006). Measurement of
CRP concentrations can however aid in assessing the
severity of the disease. In a retrospective cohort study
in 61 dogs with ultrasonographically or histologically
confirmed acute pancreatitis, there was no correlation
between this variable and outcome (Mansfield et al.,
2008). However, within a 2-day period after onset of
clinical signs, serum CRP concentrations in survivors
and non-survivors differed significantly, and were
related to severity. Therefore, sequential assessment of
serum CRP concentration may be an effective and
objective method for monitoring response to treatment
(Mansfield et al., 2008).
In cats, other acute phase proteins play a role in the
pathogenesis of acute pancreatitis. A study of 10 cats
detected a first peak of α1-acid glycoprotein (AGP)
24 hours after induction of pancreatitis, while the
greatest increase of serum amyloid A occurred 24
hours later. Further research is warranted to confirm
the possible use of these molecules in the early
detection of feline pancreatitis (Fetz et al., 2005). In
two studies, increase of α1-proteinase inhibitor was
not significant and it was only present in 20% of cats
with spontaneous disease (Fetz et al., 2004; Fetz et al.,
2005).
During the activation of trypsinogen to trypsin, a
small molecule called trypsinogen activation peptide
(TAP) is released. A significant TAP increase can be
seen in serum and urine during the first hours after the
development of pancreatitis, especially in the more se-
vere, necrotizing forms. For less severe forms, the use-
fulness is thus limited (Ruaux, 2003). Because the
onset of the disease is not known in veterinary patients,
it is possible that the concentration of TAP is already
decreasing at the time of measurement (Ruaux, 2003),
which could explain the rather low sensitivity. It is
considerably more sensitive and specific in assessing
the severity than cTLI (Mansfield et al., 2003), but its
lability and limited availability limit its usefulness
(Williams, 2000). 
TAP is detectable in the plasma and urine of cats
suspected of pancreatitis. Although serum TAP has a
higher sensitivity than fTLI in the study by Allen et al.
(2006), its measurement does not show any advantage
over determination of fTLI because of the lower spe-
cificity, high cost and limited availability. 
Plasma protease inhibitors form an important de-
fense mechanism against developing acute pancreati-
tis. Theoretically, detection of trypsin/α1-proteinase
inhibitor complexes in the circulation would be very
specific because in the absence of pancreatitis only
free trypsinogen can be found in the plasma (Ruaux,
2003; Steiner, 2003a). Unfortunately, the elevation is
not always significant due to its transient nature
(Ruaux, 2003). In cases of elevation of these molecu-
les, the increase correlates with the severity of disease
(Williams, 2000). During pancreatitis, α-macroglobu-
lines are removed from the plasma, so their concen-
tration should decrease. Unfortunately, measurement
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of these molecules is not clinically useful (Steiner,
2003a) and it is poorly correlated with the severity of
disease (Ruaux and Atwell, 1999).  
Currently, the diagnostic usefulness of canine pan-
creatic elastase and various cytokines (TNF-α, IL-6,
IL-8) is being investigated, but more clinical studies
will be required before conclusions can be drawn
(Spillman et al., 2002; Mansfield, 2004). In one study,
total TNF protein levels did not differ between groups
of dogs with varying degrees of pancreatitis (Spillman
et al., 2002).
Acute pancreatitis can cause pleural effusion and
ascites. Cytologic and biochemical analysis usually
characterize the abdominal fluid as a non-septic exu-
date, often with high lipase activity (Simpson and
Lamb, 1995; Bunch, 2003). This finding is not speci-
fic, because abdominal or intestinal trauma may also
yield the same result (Bunch, 2003).  However, accor-
ding to the study by Guija De Arespacochaga et al.
(2006), the concentration of lipase in abdominal fluid
almost always doubled the serum activity of lipase in
cases of pancreatitis. This finding can aid in diagno-
sing acute pancreatitis.  
It should be noted that none of the assays descri-
bed above are 100% specific or sensitive, and eleva-
tion of one or more enzyme(s) should always be
correlated to clinical signs and history. Unfortunately,
normal enzyme levels do not rule out a diagnosis of
acute pancreatitis (Watson, 2004; Mix and Jones,
2006). In dogs, cPLI is the most reliable test at this
moment, because of its high specificity and sensitivity.
Recently, this test became commercially available in
Belgium. Canine TLI can be considered a reasonable
alternative, although the low sensitivity can be a pro-
blem. Measurement of serum amylase and serum li-
pase has little diagnostic value and should better be
avoided. In cats, serum amylase and serum lipase have
no diagnostic use. Fortunately, alternatives have re-
cently become available. Feline PLI has both high spe-
cificity and high sensitivity, especially in severe cases.
Feline TLI is less sensitive, but still a worthy alterna-
tive.
Urinalysis
Routine analysis of a urine sample obtained before
fluids are administered can help in differentiating pre-
renal and renal azotemia and in assessing the degree
of renal damage (Simpson and Lamb, 1995; Bunch,
2003; Watson, 2004). Damage to the glomeruli by pan-
creatic enzymes can cause transient proteinuria (Simp-
son and Lamb, 1995). Urinary TAP is considered even
less accurate than serum TAP in diagnosing severe
pancreatitis, because it  was not significantly different
between healthy dogs, dogs with pancreatitis and dogs
with non-pancreatic disease (Mansfield and Jones,
2000a; Mansfield et al., 2003). However, in the study
by Mansfield and Jones (2000a), dogs that died of se-
vere pancreatitis did have higher urinary TAP than
dogs with milder forms. Another possibility is the cal-
culation of the urinary TAP-to-creatinine ratio
(UTCR), which is considered a good prognostic indi-
cator in dogs with increased values. However, it is not
recommended as a sole diagnostic tool because of the
low sensitivity (26.1%) (Mansfield and Jones, 2000b).
In contrast to dogs, the UTCR has no use in cats, be-
cause no significant difference was detected between
healthy cats and cats with pancreatitis (Allen et al.,
2006). 
CONCLUSION 
Acute pancreatitis is caused by premature
activation of pancreatic enzymes within the acinar
cells and is completely reversible. Most cases are
idiopathic, but an underlying cause can be present. It
is probably an underestimated disease in both dogs and
cats, because of unspecific clinical symptoms and the
absence of specific and sensitive tests. Routine
complete blood count, serum biochemistry and
urinalysis are a good first choice for excluding possible
differential diagnoses, for evaluating the complications
of acute pancreatitis and for assessing the general
condition of the patient. For the definitive diagnosis,
other laboratory tests must be used, of which pan -
creatic lipase immunoreactivity is currently the most
reliable test. Both canine and feline PLI have a high
sensitivity and specificity, and they both have recently
become commercially available in Belgium. Measure -
ment of canine or feline TLI is slightly less expensive
than PLI and is an alternative in areas where PLI is not
yet available. However, its low sensitivity is a
significant disadvantage. Under no condition should
measurement of serum lipase and amylase in dogs or
cats be considered a possible alternative. In dogs,
measurement of CRP or UTCR is well correlated with
severity of disease and can aid in predicting the
prognosis, but both tests are not yet widely available.
By combining the clinical signs, physical examination
findings and laboratory test results, most cases can be
readily diagnosed, which aids in rapidly initiating a
correct therapy.
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